Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
Why D.R. Horton Shares Are Trading Higher Today
Builder D.R. Horton, Inc (NYSE: DHI) shares are surging Thursday morning following its solid third-quarter FY23 results.
DHI reported sales growth of 10.7% year-over-year to $9.725 billion, beating the consensus of $8.39 billion.